Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117212 | SCV000151376 | uncertain significance | not provided | 2013-11-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000299954 | SCV000337875 | benign | not specified | 2015-12-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000117212 | SCV001098210 | benign | not provided | 2024-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354300 | SCV002660055 | benign | Inborn genetic diseases | 2019-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre de Biologie Pathologie Génétique, |
RCV001252505 | SCV001428262 | benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000117212 | SCV001800217 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000299954 | SCV001920002 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000299954 | SCV001971262 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925139 | SCV004738334 | likely benign | HCCS-related disorder | 2022-08-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |